Multivariable prognostic factor analysis with Cox-regression in the standard and sleeve lobectomy groups
. | Multivariable analysis . | |||||
---|---|---|---|---|---|---|
Standard lobectomy . | Sleeve lobectomy . | |||||
Variables . | HR . | 95% CI (lower–upper) . | P-value . | HR . | 95% CI (lower–upper) . | P-value . |
Age | ||||||
61>/61≤ | 1.755 | 1.207–2.552 | 0.003 | 1.803 | 1.195–2.720 | 0.005 |
FEV1 (ml) | ||||||
84 ≤/84 > | 1.566 | 1.098–2.234 | 0.013 | 1.303 | 0.865–1.962 | 0.205 |
T status | ||||||
T3–4/T1–2 | 1.260 | 0.815–1.948 | 0.298 | 1.001 | 0.584–1.715 | 0.997 |
N0/N1/N2 | 1.185 | 0.860–1.631 | 0.300 | 1.299 | 0.877–1.923 | 0.191 |
Pathological stage | ||||||
Stage III–IV/stage I–II | 1.134 | 0.676–1.904 | 0.633 | 1.632 | 0.871–3.059 | 0.126 |
Prognostic factor | ||||||
Present/absent | 1.194 | 0.758–1.882 | 0.445 | 1.470 | 1.139–1.899 | 0.003 |
Perineural invasion | ||||||
Present/absent | 1.599 | 0.995–2.569 | 0.052 | 2.360 | 1.446–3.851 | 0.001 |
. | Multivariable analysis . | |||||
---|---|---|---|---|---|---|
Standard lobectomy . | Sleeve lobectomy . | |||||
Variables . | HR . | 95% CI (lower–upper) . | P-value . | HR . | 95% CI (lower–upper) . | P-value . |
Age | ||||||
61>/61≤ | 1.755 | 1.207–2.552 | 0.003 | 1.803 | 1.195–2.720 | 0.005 |
FEV1 (ml) | ||||||
84 ≤/84 > | 1.566 | 1.098–2.234 | 0.013 | 1.303 | 0.865–1.962 | 0.205 |
T status | ||||||
T3–4/T1–2 | 1.260 | 0.815–1.948 | 0.298 | 1.001 | 0.584–1.715 | 0.997 |
N0/N1/N2 | 1.185 | 0.860–1.631 | 0.300 | 1.299 | 0.877–1.923 | 0.191 |
Pathological stage | ||||||
Stage III–IV/stage I–II | 1.134 | 0.676–1.904 | 0.633 | 1.632 | 0.871–3.059 | 0.126 |
Prognostic factor | ||||||
Present/absent | 1.194 | 0.758–1.882 | 0.445 | 1.470 | 1.139–1.899 | 0.003 |
Perineural invasion | ||||||
Present/absent | 1.599 | 0.995–2.569 | 0.052 | 2.360 | 1.446–3.851 | 0.001 |
CI: confidence interval; FEV1: forced expiratory volume in 1 s; HR: hazard ratio; N: node; T: tumour.
Values with P < 0.05 have been bolded.
Multivariable prognostic factor analysis with Cox-regression in the standard and sleeve lobectomy groups
. | Multivariable analysis . | |||||
---|---|---|---|---|---|---|
Standard lobectomy . | Sleeve lobectomy . | |||||
Variables . | HR . | 95% CI (lower–upper) . | P-value . | HR . | 95% CI (lower–upper) . | P-value . |
Age | ||||||
61>/61≤ | 1.755 | 1.207–2.552 | 0.003 | 1.803 | 1.195–2.720 | 0.005 |
FEV1 (ml) | ||||||
84 ≤/84 > | 1.566 | 1.098–2.234 | 0.013 | 1.303 | 0.865–1.962 | 0.205 |
T status | ||||||
T3–4/T1–2 | 1.260 | 0.815–1.948 | 0.298 | 1.001 | 0.584–1.715 | 0.997 |
N0/N1/N2 | 1.185 | 0.860–1.631 | 0.300 | 1.299 | 0.877–1.923 | 0.191 |
Pathological stage | ||||||
Stage III–IV/stage I–II | 1.134 | 0.676–1.904 | 0.633 | 1.632 | 0.871–3.059 | 0.126 |
Prognostic factor | ||||||
Present/absent | 1.194 | 0.758–1.882 | 0.445 | 1.470 | 1.139–1.899 | 0.003 |
Perineural invasion | ||||||
Present/absent | 1.599 | 0.995–2.569 | 0.052 | 2.360 | 1.446–3.851 | 0.001 |
. | Multivariable analysis . | |||||
---|---|---|---|---|---|---|
Standard lobectomy . | Sleeve lobectomy . | |||||
Variables . | HR . | 95% CI (lower–upper) . | P-value . | HR . | 95% CI (lower–upper) . | P-value . |
Age | ||||||
61>/61≤ | 1.755 | 1.207–2.552 | 0.003 | 1.803 | 1.195–2.720 | 0.005 |
FEV1 (ml) | ||||||
84 ≤/84 > | 1.566 | 1.098–2.234 | 0.013 | 1.303 | 0.865–1.962 | 0.205 |
T status | ||||||
T3–4/T1–2 | 1.260 | 0.815–1.948 | 0.298 | 1.001 | 0.584–1.715 | 0.997 |
N0/N1/N2 | 1.185 | 0.860–1.631 | 0.300 | 1.299 | 0.877–1.923 | 0.191 |
Pathological stage | ||||||
Stage III–IV/stage I–II | 1.134 | 0.676–1.904 | 0.633 | 1.632 | 0.871–3.059 | 0.126 |
Prognostic factor | ||||||
Present/absent | 1.194 | 0.758–1.882 | 0.445 | 1.470 | 1.139–1.899 | 0.003 |
Perineural invasion | ||||||
Present/absent | 1.599 | 0.995–2.569 | 0.052 | 2.360 | 1.446–3.851 | 0.001 |
CI: confidence interval; FEV1: forced expiratory volume in 1 s; HR: hazard ratio; N: node; T: tumour.
Values with P < 0.05 have been bolded.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.